Home / Import refusals / 799-3852276-4/1/1

FDA Import Refusal 799-3852276-4/1/1 — GlaxoSmithKline Research & Development Limited

GlaxoSmithKline Research & Development Limited — FEI 3003284850

The FDA refused shipment 799-3852276-4/1/1 from GlaxoSmithKline Research & Development Limited (United Kingdom) on Apr 30, 2014. The refused product falls under Drugs and Biologics — SUMATRIPTAN (ANALGESIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal details

Date
Apr 30, 2014
Country
United Kingdom
Product Category
Drugs and Biologics
Product Code
60LCA88 SUMATRIPTAN (ANALGESIC)
Charges
75

Recent inspections

Other import refusals

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.